Gyre Therapeutics, Inc. revenue breakdown overview

Gyre Therapeutics, Inc. revenue for the last year amounted to 105.76 M USD, the most of which — 105.76 M USD — came from its highest performing source at the moment, Gyre Pharmaceuticals, the year earlier bringing 113.45 M USD. The greatest contribution to the revenue figure was made by China — last year it brought Gyre Therapeutics, Inc. 105.76 M USD, and the year before that — 113.45 M USD.